申请人:Merck Sharp & Dohme Ltd.
公开号:US06559166B1
公开(公告)日:2003-05-06
A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of adverse conditions of the central nervous system, including schizophrenia and depression.
一类苯磺酰基衍生物,其中磺酰基基团也附着在N-芳基烷基取代的氮杂环丙烷、吡咯烷或哌啶环上,是人类5-HT2A受体的选择性拮抗剂,因此在治疗和/或预防中枢神经系统不良症状,包括精神分裂症和抑郁症等方面,可作为药物剂。